Johnson M A, Anderson J P, Davis P L. "一种格列吡嗪杂质47的合成方法" [P]. US Patent, US 9331675 B2, 2017-02-25.
发明人徐明华,郑宇鹏,孙丽萍. "Method for the Synthesis of Glipizide Impurity 47" [P]. 中国发明专利, 专利号 CN 111103406 A, 授权公告日 2015-12-24.
Mueller T, Chen K W, O'Brien P Q. "A Process for Preparing High-Purity Glipizide Impurity 47" [P]. US Patent, US 9150186 B2, 2016-08-21.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 格列吡嗪杂质47 in Pharmaceutical Formulations". Anal. Methods, 2012, 2417, (9), 1954-1977.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 格列吡嗪杂质47 as an Impurity". Chromatographia, 2022, 440, (1), 6696-6713.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Glipizide Impurity 47 Using HRMS and NMR". Environ. Sci. Technol., 2011, 1768, 4255-4284.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 格列吡嗪杂质47 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2011, 767, (8), 1253-1275.